+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy



Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy



British Journal of Rheumatology 33(11): 1049-1055



To compare efficacy, toxicity, and the pharmacokinetics of the combination of sulphasalazine (SASP) and methotrexate (MTX) vs MTX alone in the treatment of SASP-resistant RA we conducted a controlled open clinical trial. Forty RA patients with active arthritis despite adequate SASP therapy, were allocated randomly to regimes of either SASP + MTX or MTX alone. The patients were evaluated openly by a single observer for 24 weeks. In the first 15 patients using the combination, pharmacokinetics of MTX without and with SASP were studied. Thirty-eight patients completed the trial. The mean decrease in the disease activity score in the group of patients receiving the combination was significantly greater than in the MTX group (-2.6 vs -1.3 respectively). The same pattern was seen concerning the other efficacy variables. There was no difference in the occurrence of toxicity. SASP had no influence on the pharmacokinetics of MTX. In conclusion in this open study the efficacy of the combination of MTX and SASP seems to be superior to MTX alone, the toxicity of both therapies was similar. This effect was not explained by the pharmacokinetics of MTX which were not altered by concomitant SASP administration.

(PDF emailed within 0-6 h: $19.90)

Accession: 008344097

Download citation: RISBibTeXText

PMID: 7981992

DOI: 10.1093/rheumatology/33.11.1049


Related references

Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis. Rheumatology 37(10): 1102-1109, 1998

Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoïde Artritis. British Journal of Rheumatology 37(10): 1102-1109, 1998

Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. British Journal of Rheumatology 36(10): 1082-1088, 1997

Combination of step-down steroids, methotrexate, and sulphasalazine is cost-effective compared to sulphasalazine alone in early rheumatoid arthritis. British Journal of Rheumatology 36(SUPPL 1): 181, 1997

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52week clinical trial of sulphasalazine and methotrexate compared with the single components. Annals of the Rheumatic Diseases 58(4): 220-225, 1999

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Annals of the Rheumatic Diseases 58(4): 220-225, 1999

Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis. British Journal of Rheumatology 33(7): 651-654, 1994

Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: Pharmacokinetic analysis and relationship to clinical response. British Journal of Clinical Pharmacology 42(2): 195-200, 1996

Combination of step-down steroids, methotrexate, and sulphasalazine in early rheumatoid arthritis Excellent 1-year clinical response and low toxicity in the COBRA trial. Arthritis & Rheumatism 39(9 SUPPL ): S104, 1996

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350(9074): 309-318, 1997

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis and Rheumatism 54(1): 26-37, 2005

Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: an open-label extension of a randomized, double-blind, placebo-controlled trial. Modern Rheumatology 24(3): 410-418, 2015

Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis--tolerance of therapy. Annals of the Rheumatic Diseases 53(10): 703, 1994

Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience. British Journal of Rheumatology 34 Suppl 2: 109-112, 1995

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 58(2): 79-84, 1999